Medical Affairs Operations Consultant Clinical Development Operations Consultant

The operational challenges in global pharma are complex, requiring strategic clarity, rapid execution and compliance awareness. There is no time for on-the-job learning.


Pharma Initiatives has the experience to take immediate ownership of your biggest challenges, define a best-in-class solution and drive to results.

Our deep domain knowledge allows us to establish pharma-specific operational strategies aligning the people, processes and IT elements that must work in concert within the compliance framework for a successful change and real results for our clients.

All of our work has a common, fundamental change management methodology at its core — based on the philosophy that people will support what they create.


Embedding change within pharma is difficult people are naturally change resistant. But experience has shown that people will embrace change that they and their peers understand and are engaged in developing.

Areas of Focus


With pioneering experience in medical affairs operations, Pharma Initiatives helps our clients achieve their medical affairs goals efficiently, compliantly and measurably. 

Pharma Initiatives has decades of experience creating the strategic direction and operational infrastructure needed to consistently achieve goals in clinical development.

Pharma Initiatives has supported dozens of clients in building commercial operations to deliver needed results.

Recent Posts on Our Blog

Medical Affairs Insights – A Key Value Proposition

How does MA bring back impactful insights that drive internal stakeholder action?


The Office-based MSL

Answering a question about the practicalities of office-based MSLs 


Using Net Promoter Score to Evaluate MSLs

Is the use of Net Promoter Score measures helpful in evaluating MSLs?

FDA Settles Amarin - What It Means for MA

The FDA settled Amarin rather than lose. Why? 

Court Rules FDA Cannot Prevent Thruthful Off-label Promotion

A discussion of the breaking news on the Amarin ruling